SCHEMBL5234664

SCHEMBL5234664

CCOC(=O)[C@H](N)Cc1cc(C)c(N)c(Cl)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CPB2 Q96IY4 1/20 0.40
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
GAA P10253 2/20 0.36
HPGD P15428 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HSD11B1 P28845 2/20 0.36
SLC7A5 Q01650 1/20 0.35
THRA P10827 2/20 0.35
THRB P10828 2/20 0.35
GLA P06280 1/20 0.35
TPH1 P17752 2/20 0.34
CYP4F2 P78329 1/20 0.34
CYP4A11 Q02928 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
ABCB1 P08183 1/20 0.33
SCN9A Q15858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5235272 0.86 THRB (0.40) CPB2TSHRKDM4EALDH1A1GAA
SCHEMBL4800520 0.84 SLC7A5 (0.47) KDM4ESLC7A5THRATHRBTDP1
SCHEMBL4800531 0.84 SLC7A5 (0.47) KDM4ESLC7A5THRATHRBTDP1
SCHEMBL3310473 0.83 ADRB2 (0.41) CPB2HPGDHSD11B1TPH1
SCHEMBL3311167 0.83 ADRB2 (0.41) CPB2HPGDHSD11B1TPH1
SCHEMBL4717979 0.81 SMN1; SMN2 (0.43) TSHRSMN1; SMN2KDM4EALDH1A1SLC7A5
SCHEMBL4800166 0.80 CYP3A4 (0.45) CPB2TSHRSMN1; SMN2KDM4EALDH1A1
Hydrochloric Acid SCHEMBL3312834 0.80 SMN1; SMN2 (0.43) TSHRSMN1; SMN2KDM4EALDH1A1SLC7A5
SCHEMBL21117866 0.79 SMN1; SMN2 (0.55) TSHRSMN1; SMN2KDM4EALDH1A1GAA
SCHEMBL4721770 0.79 THRB (0.38) CPB2SLC7A5THRATHRBTPH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1737842-A1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCING THE SAME AND THE USE THEREOF AS DRUGS Boehringer Ingelheim International GmbH (DE) 2007-01-03 EP disclosed
WO-2005100343-A1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCING THE SAME AND THE USE THEREOF AS DRUGS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-10-27 WO disclosed